About Us
Who We Are
At SS Pharma Group, we are driven by a mission to enhance global healthcare through the development and supply of high-quality Intermediates and Key Starting Materials (KSMs). Headquartered in India, we serve a diverse clientele across domestic and international markets.
With a strong foundation in scientific innovation and a deep commitment to compliance, we specialize in the development of complex and niche intermediates—particularly in therapeutic areas such as oncology and diabetes. Our experienced R&D and manufacturing teams work collaboratively to ensure that every product meets stringent global regulatory standards and customer-specific requirements.
Our R&D Services
The primary aim of SS Pharma Group is to establish ourselves as a leading research-oriented company focused on the development of high-value pharmaceutical intermediates and key starting materials (KSMs). We are deeply invested in advancing our R&D capabilities—allocating substantial resources to research activities and continually upgrading our supporting infrastructure.
Our innovation is driven by a team of experienced and dedicated scientists who work relentlessly to explore novel synthetic pathways and develop cost-effective, scalable solutions. From idea generation to lab validation and beyond, our team focuses on delivering high-quality intermediates tailored to meet global market demands.
We also offer customized R&D services to address the specific and evolving needs of our clients. Confidentiality is paramount, and we ensure strict protection of intellectual property for all contract or exclusive development projects.
- Identification and synthesis of impurities for Intermediates
- Synthesis of new molecules, including many chiral molecules.
- Scale up of products from grams to kilograms
Top Management
At SSPharma, our leadership team is driven by innovation, expertise, and a commitment to excellence. Each member brings a wealth of experience and a shared vision to guide our company forward, ensuring we deliver the highest quality solutions to our clients.
John Doe
Position name
John Doe
Position name
John Doe
Position name
Committed to Chemistry, Focused on the Future
At SS Pharma Group, we are committed to shaping the future of pharmaceutical manufacturing through our unwavering focus on the development of high-quality Intermediates and Key Starting Materials (KSMs). With a strong presence in both domestic and international markets, we are known for our deep-rooted expertise in process chemistry, regulatory awareness, and quality assurance.
Our journey is driven by a passion for precision, innovation, and customer satisfaction. By combining scientific excellence with operational discipline, we deliver reliable and consistent products that cater to some of the most demanding therapeutic segments-including oncology and chronic disease treatment.
What sets us apart is our ability to provide tailored solutions through advanced R&D, scalable manufacturing, and a collaborative approach that fosters long-term partnerships with our clients. Chemistry is not just our business—it’s our commitment to better healthcare.
Why Us?
We are driven by a team of experienced scientists who focus on developing high-quality KSMs, intermediates, and CDMO solutions. Along with this, we offer a wide range of R&D services tailored to customer needs, maintaining strict confidentiality for exclusive projects. Our aim is to establish SSPharma as a leading research-driven organization, investing continuously in R&D resources and innovation to deliver reliable solutions that support our partners’ growth.
Attributes of our organization
- CRDMO Services Since 2010
- GMP Approved Lab in USA
- FDA-registered for intermediates
- ISO 9001:2015
- GEN AI Tool Integrated with SciFinder and ReAxys
ADVANTAGE
Our clients are different, but they all share the need to have a software solution built to generate revenue streams, establish communication channels or streamline business operations.
WHAT WE DO
As global leaders in IT services and business solutions, we partner with clients to simplify, strengthen, and transform their businesses.
OUR CUSTOMRES
Today, customer experience defines the brand, analytics overrule instincts, and innovation, insight, and agility—not size—defines winners.
OUR TALENT
At O2 Technologies, we are committed to delivering maximum value to our clients to help them succeed in a constantly changing and challenging business world.
How we innovate
At O2 Technologies, we take an innovation-led approach to help clients "imagine and invent" their future. Through the Accenture Innovation Architecture, we combine our capabilities to invent, develop, and deliver disruptive innovations.
As part of O2 Technologies's Innovation Architecture, our Research team shapes trends and creates data-driven thought leadership about the most pressing issues global organizations face.
Ventures
O2 Technologies Ventures partners with and invests in growth-stage companies that create innovative enterprise technologies using an open innovation approach.
Labs
O2 Technologies Labs does cutting edge research and incubates new concepts through applied R&D projects that have a significant near-term impact on our clients’ businesses.
Studios
O2 Technologies Studios focus on a range of specializations from rapid application development to service design and digital project creation to mobile apps and digital services.
Innovation Centers
O2 Technologies Innovation Centers are located strategically worldwide, building and scaling solutions across technologies and industries.
Delivery Centers
O2 Technologies’s Delivery Centers industrialize the delivery of our innovations through our unparalleled network of more than 50 delivery centers around the world.